1.Changes of Immunologic Function,Cellular Factor,Genotype and Activities of Platelet Activating Factor-Acetylhydrolase in Different Stadium of Mycoplasma Pneumoniae Pneumonia of Infant
Journal of Applied Clinical Pediatrics 1994;0(04):-
0.05).Conclusions Immunologic function alteration of MPP of infants is showed mainly that Th1 immunologic response is raised,Th2 immunologic response is abated,the cellular factor are changed horizontally,but the immunology index and cellular factor are recovered quickly.There are no relations between MPP of infant and PHF-AH genotype,but there is a downward trend in activity of PHF-AH in acute stage.
2.Development of HTS model on SERT inhibitors combined biological screening model with HTVS.
Rui ZHAO ; Jian-song FANG ; Ai-lin LIU ; Guan-hua DU
Acta Pharmaceutica Sinica 2015;50(9):1116-1121
In order to improve the efficiency of drug screening on serotonin transporter (SERT) inhibitors, a high-throughput screening (HTS) model is established in RBL-2H3 cells. The RBL-2H3 cells are very similar to the serotonin genetic neuro, in modulation of post-receptor mechanisms and transduction pathway of SERT reactivated. Depending on a fluorescence substrate ASP+ used in detection method of inhibitor rates, it's convenient, quick, accurate and effective, not making the environmental biohazard compared with radioactive experiments. Furthermore, biological screening model combined with computer aided virtual screening technique describing high-throughput virtual screening (HTVS). Bayesian classification method and molecular fingerprint similarity were applied to virtual screening technique, for screening compounds in compound library. Some compounds have been found, and then validated further by biological screening model. Combination of HTS and HTVS improves the efficiency of screening SERT inhibitors.
Animals
;
Bayes Theorem
;
Cell Line
;
Drug Evaluation, Preclinical
;
High-Throughput Screening Assays
;
Models, Biological
;
Rats
;
Serotonin Plasma Membrane Transport Proteins
;
metabolism
;
Serotonin Uptake Inhibitors
;
pharmacology
3.Progress on the application of artificial intelligence technology in ligand-based and receptor structure-based drug screening
Run-zhe LIU ; Jun-ke SONG ; Ai-lin LIU ; Guan-hua DU
Acta Pharmaceutica Sinica 2021;56(8):2136-2145
Artificial intelligence technology is being widely applied in drug screening. This paper introduces the characteristics of artificial intelligence, and summarizes the application and progress of artificial intelligence technology especially deep learning in drug screening, from ligand-based and receptor structure-based aspects. This paper also introduces how to apply artificial intelligence to drug design from these two aspects. Finally, we discuss the main limitations, challenges, and prospects of artificial intelligence technology in the field of drug screening.
4.Network pharmacology: new guidelines for drug discovery.
Acta Pharmaceutica Sinica 2010;45(12):1472-1477
The development of new drug is not only the main driving force for the development of pharmaceutical industry, but also plays a very important role in the social development. However, with the increasing demands, new drug development is facing great difficulties in recent years. The hypothesis of highly selective single-target is meeting the challenges because of its limitations. Network pharmacology has been one of the new strategies for new drug discovery based on single-target drug research in recent years. This paper focused on the basis of network pharmacology and its research progress, discussed its development direction and application prospects, and analyzed its limitations and problems as well. The application of network pharmacology in new drug development is discussed by comparing its guidelines with those of traditional Chinese medicine theory and Effective Components Group hypothesis of Chinese medicines.
Algorithms
;
Animals
;
Computational Biology
;
methods
;
Drug Delivery Systems
;
methods
;
Drug Discovery
;
methods
;
Drug Interactions
;
Humans
;
Medicine, Chinese Traditional
;
methods
;
Software
;
Systems Biology
;
methods
5.Research advance in the drug target prediction based on chemoinformatics.
Jian-song FANG ; Ai-lin LIU ; Guan-hua DU
Acta Pharmaceutica Sinica 2014;49(10):1357-1364
The emerging of network pharmacology and polypharmacology forces the scientists to recognize and explore new mechanisms of existing drugs. The drug target prediction can play a key significance on the elucidation of the molecular mechanism of drugs and drug reposition. In this paper, we systematically review the existing approaches to the prediction of biological targets of small molecule based on chemoinformatics, including ligand-based prediction, receptor-based prediction and data mining-based prediction. We also depict the strength of these methods as well as their applications, and put forward their developing direction.
Computational Biology
;
Data Mining
;
Drug Delivery Systems
;
Drug Design
;
Ligands
6.Research progress of virtual screening aided drug discovery.
Acta Pharmaceutica Sinica 2009;44(6):566-570
In the process of new drug discovery, the application of virtual screening can enrich active compounds, reduce the cost of drug screening, and increase the feasibility of drug screening. Therefore virtual screening technology has become an important approach for new drug discovery. As virtual screening and bioactivity screening possess different advantages, their combination can effectively promote new drug discovery. In the present paper, the application and the trend of removal of non-drug compounds, removal of false positive compounds, pharmacophore searching, molecular docking, and molecular similarity in the process of drug discovery are introduced in order to obtain more benefit from virtual screening strategy for new drug discovery.
Drug Design
;
Drug Discovery
;
Drug Evaluation, Preclinical
;
Models, Molecular
7.Network mechanism on effective constituents from Polygala Tenuifolia for anti-Alzheimer Disease
Hao JIA ; Xiao-Cong PANG ; Bao-Yue ZHANG ; Zhe WANG ; Ai-Lin LIU ; Guan-Hua DU
Chinese Journal of Pharmacology and Toxicology 2018;32(4):287-288
OBJECTIVE To clarify out the network pharmacology mechanism of Polygala tenuifolia against Alzheimer disease(AD).METHODS Firstly,we collected the chemical constituents from Polyg-ala tenuifolia and key targets toward AD.Machine learning algorithms were applied to construct classifi-ers for predicting the effective constituents. Secondly, docking models were utilized for further evalua-tion.Finally,we built constituent-target,target-target network and target-biology pathway network.RE-SULTS 104 chemical constituents Polygala tenuifolia from were collected.Through prediction of blood-brain penetration and validation,36 chemical constituents were selected among 100 chemical constitu-ents,their action targets mainly focused on AChE,COX-2,TNF-α,insulin-degrading enzyme and APP. Their main structure types include Polygala saponins, Polygala glycosides, Polygala shrubby ketones, polygala xanthones and sterols,which acted on AchE,APP,M-TAU,GSK3β and 5HT1A with high fre-quency.Gene-Ontology and KEGG enrichment analysis showed that the main pathways of these con-stituents involve in neurotransmitter release,synaptic conduction and synaptic plasticity,apoptosis reg-ulation,phosphorylation pathway,Ca2+signaling pathway,and so on.CONCLUSION This study uncov-ered a network mechanism of Polygala tenuifolia against Alzheimer disease,which may provide impor-tant information for the further study and new drug development.
8.Network mechanism of effective constituents from the compound Yizhihao against influenza
Lyu-Jie XU ; Hao JIA ; Wen JIANG ; Jian-Guo XING ; Ai-Lin LIU ; Guan-Hua DU
Chinese Journal of Pharmacology and Toxicology 2018;32(4):320-320
Influenza caused by influenza virus,seriously threaten human life and health.Drug treatment is one of the effective measurement. However, there are only two classes of drugs, one class is M2 blockers and another is neuraminidase (NA)inhibitors. The recent antiviral surveillance studies reported a global significant increase in M2 blocker resistance among influenza viruses, and the resistant virus strains against NA inhibitor are also reported in clinical treatment.Therefore thediscovery of new medicines with low resistance has become very urgent.As all known,traditional medicines with multi-target features and network mechanism often possess low resistance. Compound Yizhihao, which consists of radix isatidis,folium isatidis,Artemisia rupestris,is one of the famous traditional medicine for influenza treatment in China, however its mechanism of action against influenza is unclear. In this study, the multiple targets related with influenza disease and the known chemical constituents from Compound Yizhihao were collected, and multi-target QSAR (mt-QSAR) classification models were developed by Na?ve Bayesian algorithm and verified by various datasets. Then the classification models were applied to predict the effective constituents and their drug targets.Finally,the constituent-target-pathway network was constructed,which revealed the effective constituents and their network mechanism in Compound Yizhihao. This study will lay important basis for the clinical uses for influenza treatment and for the further research and development of the effective constituents.
9.Effect of early nursing intervention on the myocarditis patients suffering from acute upper respiratory tract infection
Ai-Long HU ; Jia-Hua HU ; Sheng-Hua DU
Chinese Journal of Modern Nursing 2013;19(21):2525-2527
Objective To study the effect of early care intervention on the myocarditis patients suffering from acute upper respiratory tract infection.Methods Totals of 78 patients were randomly divided into two groups,each with 39 cases.The control group received conventional care,while the intervention group received early nursing intervention on the basis of routine care.Results After two weeks,the total effective rate of the intervention group was 97.4%,higher than 87.2% in the control group,and the difference was statistically significant (Z =2.434,P < 0.05).The cTnI and myocardial enzymes of the two groups were significantly decreased compared with before (P < 0.05).And indicators of intervention group decreased significantly compared with that of the control group (t =4.189,3.289,3.260,3.488,respectively ; P < 0.05).On the care evaluation,the total satisfaction of the control group was 84.6% (33/39),which was lower the intervention group that was 97.4% (Z =3.017,P < 0.05).Conclusions Early care intervention on the myocarditis patients suffering from acute upper respiratory tract infection has positive clinical value.
10.Evaluation of Chinese traditional patent medicines against influenza virus in vitro.
Mian ZU ; Dan ZHOU ; Li GAO ; Ai-lin LIU ; Guan-hua DU
Acta Pharmaceutica Sinica 2010;45(3):408-412
To study in vitro anti-influenza viral activities of Chinese traditional patent medicines for influenza prevention and treatment, neuraminidase (NA) activity assay was used to examine NA inhibitory activity of 33 Chinese traditional patent medicines through fluorimetric assay, and influenza virus induced cytopathic effect (CPE) inhibition assay was used to verify their anti-influenza viral activities in vitro. The assay results showed that most liquid preparations displayed relatively high NA inhibitory activities, such as Shuanghuanglian oral liquid, Qingkailing oral liquid, Qingre Jiedu oral liquid, and Reduning injection. Among liquid preparations, Shuanghuanglian oral liquid not only displayed the highest NA inhibitory effect, but also exhibited obvious in vitro anti-viral activity in CPE experiment. Among solid preparations, Shuanghuanglian powder for injection showed the highest activity on NA inhibition, and Fufang Yuxingcao tablet showed relatively strong anti-influenza viral activity in CPE cells. From the results, it can be concluded that most Chinese traditional patent medicines possessed NA inhibitory activity, but only a few of them displayed significant in vitro anti-influenza viral activities. These results will provide important information for the isolation of active constituents, and for the clinical uses of Chinese traditional patent medicines for influenza treatment and prevention.
Animals
;
Antiviral Agents
;
pharmacology
;
Cell Line
;
Cytopathogenic Effect, Viral
;
drug effects
;
Dogs
;
Dose-Response Relationship, Drug
;
Drugs, Chinese Herbal
;
administration & dosage
;
isolation & purification
;
pharmacology
;
Influenza A Virus, H1N1 Subtype
;
drug effects
;
enzymology
;
Influenza A Virus, H3N2 Subtype
;
drug effects
;
enzymology
;
Influenza B virus
;
drug effects
;
enzymology
;
Medicine, Chinese Traditional
;
Neuraminidase
;
antagonists & inhibitors
;
metabolism
;
Plants, Medicinal
;
chemistry